All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

1,268

Reset

1,268 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • WJ22096Phase 21 trial

    Nanjing Jingao biomidical technology Co. Ltd. · Advanced Solid Tumors

  • WTX-330Phase 21 trial

    Werewolf Therapeutics, Inc. · Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma

  • XER-001Phase 21 trial

    Xerient Pharma · Locally Advanced Pancreatic Adenocarcinoma, Locally Advanced Pancreas Cancer, Locally Advanced Pancreatic Ductal Adenocarcinoma

  • XNW29016PARGiPhase 21 trial

    Evopoint Biosciences Inc. · Tumor, Solid

  • XNW34017Phase 21 trial

    Evopoint Biosciences Inc. · Advanced Solid Tumors

  • XP-102Phase 21 trial

    Xynomic Pharmaceuticals, Inc. · Cancer, BRAF V600 Mutation, Melanoma

  • XS-03Phase 21 trial

    Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. · Colorectal Cancer, Metastatic Colorectal Cancer With RAS Mutation

  • XTX202Phase 21 trial

    Xilio Development, Inc. · Advanced Solid Tumor

  • XTX301Phase 21 trial

    Xilio Development, Inc. · Advanced Solid Tumor

  • XTX501Phase 21 trial

    Xilio Development, Inc. · Metastatic NSCLC - Non-Small Cell Lung Cancer, Advanced Solid Tumor

  • XYA02Phase 21 trial

    XYone Therapeutics, Inc · MUC1-expressing Advanced, Relapsed and/or Refractory Solid Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer

  • XZP-5955Phase 21 trial

    Xuanzhu Biopharmaceutical Co., Ltd. · Locally Advanced or Metastatic Solid Tumors, Locally Advanced or Metastatic Non-small Cell Lung Cancer

  • Y101DPhase 21 trial

    Wuhan YZY Biopharma Co., Ltd. · Advanced Pancreatic Adenocarcinoma

  • YH32364Phase 21 trial

    Yuhan Corporation · EGFR Overexpression, Locally Advanced Solid Tumor, Metastatic Solid Tumor

  • YH32367Phase 21 trial

    Yuhan Corporation · HER2-Positive Solid Tumor

  • YH42946Phase 21 trial

    Yuhan Corporation · NSCLC (Non-small Cell Lung Cancer), Solid Tumor

  • YL-13027Phase 21 trial

    Shanghai YingLi Pharmaceutical Co. Ltd. · Metastatic Pancreatic Cancer

  • ZL-85FAPhase 21 trial

    Chengdu Zenitar Biomedical Technology Co., Ltd · Advanced Solid Tumor

NewerPage 26 of 26

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.